Donald Trump's latest White House health check has revived scrutiny over his weight, aspirin use and whether a GLP-1 drug such as Ozempic ought to be part of the picture, after one Stanford doctor said the president appears overweight and is in a group where such medication is now commonly prescribed.
The news came after Trump returned to Walter Reed National Military Medical Center on 26 May for what the White House described as a routine annual medical and dental assessment, even though he had already had a yearly checkup in April 2025 and another publicised visit in October. The timing has fed the usual chatter around the 79-year-old president's health, especially as he approaches his 80th birthday next month and remains the oldest person ever elected to the office.
